SCHEMBL14070193

SCHEMBL14070193

Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nn(C)c2nc(Nc3ccccc3)ncc12

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 7/20 0.75
SYK P43405 2/20 0.65
LCK P06239 4/20 0.61
BRAF P15056 7/20 0.58
ABL1 P00519 3/20 0.58
TNK2 Q07912 2/20 0.58
MAP4K2 Q12851 2/20 0.58
SRC P12931 2/20 0.58
DDR1 Q08345 2/20 0.58
MAPK14 Q16539 2/20 0.58
DDR2 Q16832 2/20 0.58
ESYT2 A0FGR8 1/20 0.58
PLEKHG3 A1L390 1/20 0.58
NBAS A2RRP1 1/20 0.58
CNOT1 A5YKK6 1/20 0.58
TBKBP1 A7MCY6 1/20 0.58
MYO1G B0I1T2 1/20 0.58
AGPS O00116 1/20 0.58
MYO1F O00160 1/20 0.58
SNAP23 O00161 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14070246 0.93 BTK (0.72) BTKSYKLCKBRAFABL1
SCHEMBL14070255 0.92 BTK (0.73) BTKSYKLCKBRAFABL1
SCHEMBL14069733 0.92 BTK (0.74) BTKSYKLCKBRAFABL1
SCHEMBL14070244 0.91 BTK (0.72) BTKSYKLCKBRAFABL1
SCHEMBL14070254 0.90 BTK (0.73) BTKSYKLCKBRAFABL1
SCHEMBL14070242 0.89 BTK (0.69) BTKLCKBRAFABL1SRC
SCHEMBL14070166 0.89 BTK (0.70) BTKSYKLCKBRAFABL1
SCHEMBL14069588 0.88 BTK (0.67) BTKSYKLCKBRAFABL1
SCHEMBL20558521 0.88 BTK (0.67) BTKSYKLCKBRAFABL1
SCHEMBL14070195 0.88 BTK (0.69) BTKSYKLCKBRAFABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008112695-A2 PYRAZOLO [3,4-D] PYRIMIDINES AND 1, 2, 5, 6-TETRAAZA- AS- INDACENES AS PROTEIN KINASE INHIBITORS FOR CANCER TREATMENT IRM LLC (BM) 2008-09-18 WO disclosed